1,25-Dihydroxyvitamin D3 increased β-adrenergic adenylate cyclase response of fetal rat keratinizing epidermal cells (FRSK cells)

Journal of Dermatological Science

Volumn 11, Issue 2, 1996, Pages 121-128

  Takahashi, Hidetoshi ^a   Tamura, Toshiya ^a   Iizuka, Hajime ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

1,25 Dihydroxyvitamin D3; cAMP; dCTP; Fetal rat keratinizing epidermal cell

Indexed keywords

ADENOSINE; ADENYLATE CYCLASE; ADRENALIN; BETA 2 ADRENERGIC RECEPTOR; CALCITRIOL; CYCLIC AMP; DEXAMETHASONE; HISTAMINE; ISOBUTYLMETHYLXANTHINE; PAPAVERINE; PROSTAGLANDIN E2;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EPIDERMIS; FETUS; KERATINIZATION; NONHUMAN; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; RAT;

EID: 0029670729     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/0923-1811(95)00428-9     Document Type: Article

References (33)

1. 3 Endocrinology 113: 1950-1957, 1983.
2. 3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol 86: 706-714, 1986.
3. 3 receptors in human skin biopsies. J Clin Endocrinol Metabol 51: 1463-1465, 1980.
4. 3. J Clin Endocrinol Metabol 56: 824-830, 1983.
5. 3 on normal human keratinocytes cultured in serum-free medium. Biochem Biophys Res Commun 166: 916-923 1990.
6. Harris RR, Mackenzie IC: The effects of α and β adrenergic agonists and cyclic adenosine 3′,5′-monophosphate on epidermal metabolism. J Invest Dermatol 77: 337-340, 1981.
7. Orenberg EK, Pfendt EA, Wilkinson DI: Characterization of α and β adrenergic agonist stimulation of adenylate cyclase activity in human epidermal keratinocytes in vitro. J Invest Dermatol 80: 503-507, 1983.
8. Yoshikawa K, Adachi K, Halprin KM, Levine V: On the lack of response to catecholamine stimulation by the adenyl cyclase system in psoriatic lesions, Br J Dermatol 92: 619-624 1975.
9. Iizuka H, Adachi K, Halprin KM, Levine V: Cyclic AMP accumulation in psoriatic skin; differential responses to histamine, AMP, and epinephrine by the uninvolved and involved epidermis. J Invest Dermatol 70: 250-253, 1978.
10. Iizuka H, Matsuo S, Tamura T, Ohkuma N: Increased cholera toxin-, and forskolin-induced cyclic AMP accumulations in psoriatic involved versus uninvolved or normal human epidermis. J Invest Dermatol 91: 154-157, 1988.
11. Itami S, Kino J, Halprin KM, Adachi K: Immunohistchemical study of beta-adrenergic receptors in psoriatic epidermis using an anti-alprenolol anti-idiotypic antibody. Arch Dermatol Res 279: 324-327, 1987.
12. 3 treatment in psoriasis vulgaris. Br J Dermatol 115: 421-429 1988.
13. 3 analogue, 1,24-hidroxycholecalciferol. Br J Dermatol 115: 431-433, 1986.
14. Smith EL, Pincus SH, Donovan L, Holick MF: A novel approach for the evaluation and treatment of psoriasis. J Am Acad Dermatol 19: 516-528, 1988.
15. 3 analogue (MC903) in a double-blind study. Br J Dermatol 119: 223-230, 1988.
16. 2-adrenergic receptors in keratinocytes: glucocorticoids increased steady state levels of receptor mRNA in fetal rat keratinizing epidermal cells. Br J Dermatol 124: 341-347, 1991.
17. Takahashi H, Iizuka H: Retinoid-induced beta-adrenergic inhibitory effect associated with increased thymidine incorporation of fetal rat keratinizing epidermal cells (FRSK cells). J Dermatol Sci 5: 122-129, 1993.
18. Indo K, Miyaji H: Quantitative changes in the biologic characteristics of cultured fetal rat keratinizing epidermal cell during the process of malignant transforrmation after benzo[a]pyrene treatment. J Natl Cancer Inst 63: 1017-1027 1979, 1979.
19. Takahashi H, Tamura T, Tsutsui M, lizuka H: Adenylate cyclase system of FRSK cells and SV40-transformed human keratinosytes. J Dermatol (Tokyo) 17: 457-464, 1990.
20. Maniatis T, Fritsh EF, Sambrook T: Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory, 1989.
21. 2-adrenergic receptor. Proc Natl Acad Sci USA 84: 46-50, 1987.
22. Matsuo S, Iizuka H: Cholera toxin- and forskolin-induced cyclic AMP accumulations of pig skin (epidermis). J Dermatol Sci 1: 7-14, 1990.
23. Iizuka H, Kishiyama K, Ohkawara A: Regulation of beta-adrenergic adenylate cyclase responsiveness of pig skin epidermis by suboptimal concentrations of epinephrine. J Invest Dermatol 81: 549-552, 1983.
24. Cremoux P, Calvo F, Cost H, Gauville C, Lagier G Abita JP, Lechat P: 1,25-Dihydroxycholecalciferol induce an increase in PGE1 and forskolin-stimulated cyclic AMP production in T47D human breast cancer cell line. Fundam Clin Pharmacol 1: 347-356, 1987.
25. 3 modulates adenylate cyclase activity of human breast cancer cell line T47D though increased synthesis of Gs. Biochem Pharmcol 38: 3111-3114, 1989.
26. Ozono K, Liao J, Kerner SA, Scott RA, Pike JW: The vitamin D-responsive element in the human osteocalcin gene. J Biol Chem 265: 21881-21888, 1990.
27. 3 receptors. Cell 65: 1255-1266, 1991
28. Zhang X, Hoffmann B, Tran P, Graupner G, Pfahl M: Retinoid X receptors is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 355: 441-446, 1992.
29. 3 signalling. Nature 355 : 446-449, 1992.
30. 3 is linked to dephosphorylation of retinoblastoma gene product. Biochem Biophys Res Commun 196:487-493, 1993.
31. 3, but fail to respond to its prodifferentiating effect. J Invest Dermatol 97: 435-441, 1991.
32. 3 on normal and psoriatic keratinocytes. Br J Dermatol 123: 93-98, 1990.
33. 3 on adenylate cyclase and protein kinase C in pig skin. Acta Dermatol Venereol (Stockholm) 71: 6-11, 1991.